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Abstract 
Synucleins are involved in multiple steps of the neurotransmitter turnover but the 
largely normal synaptic function in young adult animals completely lacking 
synucleins suggests their roles are dispensable for execution of these processes. 
Instead, they may be utilized for boosting the efficiency of certain molecular 
mechanisms in presynaptic terminals, with a deficiency of synuclein proteins 
sensitizing to or exacerbating synaptic malfunction caused by accumulation of mild 
alterations, which are commonly associated with aging.  Although functional 
redundancy within the family has been reported, it is unclear whether the remaining 
synucleins can fully compensate for the deficiency of a lost family member, or 
whether some functions are specific for a particular member. We assessed several 
structural and functional characteristics of the nigrostriatal system of mice lacking 
members of the synuclein family in every possible combination and demonstrated that 
stabilization of the striatal dopamine level depends on the presence of α-synuclein and 
cannot be compensated for by other family members, whereas β-synuclein is required 
for efficient maintenance of animal’s balance and coordination in old age. 
 
Key words: synuclein/nigrostriatal system/knockout mice/null 
mutant/Parkinson’s disease/dopamine 
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1. Introduction 
Among several proteins whose malfunction has been linked to molecular events 
leading to neuronal dysfunction in Parkinson’s disease (PD), α-synuclein deservingly 
hold the status of a primary culprit due to its causative role in certain familial forms 
and a pivotal role in the formation of histopathological hallmarks in both familial and 
idiopathic forms of the disease (reviewed in (Dev et al., 2003; Venda et al., 2010)). 
Moreover, polymorphisms within the locus encoding α-synuclein have been found to 
be associated with the increased risk of PD development (Kay et al., 2008; Mizuta et 
al., 2008; Pankratz et al., 2009; Scholz et al., 2009; Sutherland et al., 2009), with 
recent studies suggesting that disease progression to the symptomatic stage correlates 
with the spreading of pathological α-synuclein aggregates to dopaminergic neurons of 
the substantia nigra pars compacta (SNpc) (Braak et al., 2006; Desplats et al., 2009; 
Luk et al., 2012; Recasens et al., 2014). 
 
Aggregation of α-synuclein not only generates various products intrinsically toxic for 
neurons but also depletes the pool of functional α-synuclein, particularly in 
presynaptic terminals, its normal site of localisation and function. The importance of 
α-synuclein for the efficient function of vertebrate presynaptic neurotransmitter 
storage and release machinery has been demonstrated in experiments with live 
animals or primary neurons derived from either animals overexpressing various forms 
α-synuclein or depleted of endogenous α-synuclein by targeted inactivation of Snca, 
gene encoding mouse α-synuclein (Abeliovich et al., 2000; Cabin et al., 2002; 
Chandra et al., 2004; Chandra et al., 2005; Janezic et al., 2013; Lim et al., 2010; Lin 
et al., 2012; Nemani et al., 2010; Senior et al., 2008; Taylor et al., 2014; Yavich et al., 
2006; Yavich et al., 2005; Yavich et al., 2004). 
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However, in models with transgenic α-synuclein expression it is problematic to 
identify the chain of events leading to alterations of synaptic functions. A modified or 
overexpressed exogenous α-synuclein may hijack and compromise the endogenous α-
synuclein function. Alternatively, functional alterations may be caused by the novel 
gain-of-function effects of the exogenous α-synuclein, which can be completely 
unrelated to any of normal functions of the endogenous protein or affect them only 
indirectly. On the other hand, interpretation of experimental data obtained in α-
synuclein null mutant mice is complicated by the expression in vertebrate neurons, 
including dopaminergic neurons of SNpc, of two closely related members of the 
synuclein family, β-synuclein and γ-synuclein. These two proteins are not known to 
be directly involved in aetiology or pathogenesis of PD but can function in the same 
molecular processes in neuronal synapses as α-synuclein and therefore, compensate, 
at least partially, for its loss. This functional redundancy might mask consequences of 
α-synuclein depletion in the SNpc of null mutant mice.  
 
In the absence of the interfamily compensation, i.e. following inactivation of all three 
synuclein-encoding genes, animals develop more pronounced behavioral, 
physiological and biochemical changes in their nervous system, including the 
nigrostriatal axis, than animals with null mutations for one or two of these genes. 
Importantly, synaptic malfunction develops gradually and its manifestations become 
detectable only in aging triple synuclein null mutant mice (Anwar et al., 2011; Burre 
et al., 2010; Greten-Harrison et al., 2010). These observations suggest that the 
presence of synucleins delays functional decline of neuronal synapses in the aging 
nervous system. However, the impact of each family member on this process might be 
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different. Indeed, a significant, although not sufficient to cause functional alterations, 
decrease of striatal dopamine level has been observed only in adult α/β-synuclein 
double and aged α-synuclein, but not in adult α/γ-synuclein double and aged γ-
synuclein null mutant mice (Al-Wandi et al., 2010; Chandra et al., 2004; Robertson et 
al., 2004).   
 
For synucleins, as any other proteins that affect efficiency rather than execution or 
robust regulation of intracellular processes, it is particularly important to consider 
effects of external factors when comparing data obtained in different setups. In 
particular, for studies of mice lacking such proteins genetic background and 
environmental conditions might significantly affect experimental data, and at least 
some discrepancies in results obtained in similar studies of synuclein null mutant 
mice carried out in different laboratories may have been caused by differences in 
these parameters. 
 
Therefore, to address the role of each member of the synuclein family in maintaining 
the efficiency of the nigrostriatal system function in aged animals we carried out a 
breeding programme aimed to produce mouse lines lacking one, two or all three 
synucleins and control wild type mice, on the same C57Bl6/J genetic background, and 
systematically studied motor behavior and major parameters of the nigrostriatal 
system in cohorts of aged mice of all eight genotypes. 
   
 
2. Material and methods  
2.1. Generation of double and triple synuclein null mutant animals  
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Generation of α-synuclein, γ-synuclein and α-synuclein/γ-synuclein double null 
mutant mice on C57Bl6J (Charles River) background was described previously 
(Abeliovich et al., 2000; Ninkina et al., 2003; Robertson et al., 2004). Heterozygous 
β-synuclein null mutant mice (Chandra et al., 2004) on C57Bl6J background were 
further backcrossed with C57Bl6J (Charles River) mice for 6 generations in the 
Cardiff University Transgenic Animal Unit before breeding with α-synuclein/γ-
synuclein double null mutant mice. Resultant triple heterozygous animals were 
intercrossed to produce founders of triple null mutant, double null mutant and wild 
type colonies used in this study. Thus, all studied animals were on the same C57Bl6J 
(Charles River) genetic background. Mice were maintained in conventional open-lid 
cages with ad libitum access to standard chow and water. Mouse genotyping was 
carried out as described previously (Chandra et al., 2004; Ninkina et al., 2003; 
Robertson et al., 2004). Animals were sacrificed by a Schedule 1 method or 
terminally anaesthetised followed by perfusion fixation, and tissues were collected 
and coded. Individuals that performed all further analyses were blinded to the sample 
genotype. All animal work was carried out in accordance with the United Kingdom 
Animals (Scientific Procedures) Act (1986). 
 
2.2. Behavioral tests 
2.2.1. Inverted grid test  
Mice were placed onto a 30 cm by 30 cm square mesh consisting of 5 mm squares of 
0.5 mm diameter wire. The grid was slowly rotated to the inverted position and held 
above a thick layer of bedding material. If a mouse fell from the grid earlier than the 
maximum test time of 1 min the latency to fall was noted and after a 10 min rest 
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period in the home cage the test was repeated. The best result from three attempts was 
included in the statistics.  
2.2.2. Rotarod test  
Mice were trained and then tested for 5 min on the accelerating (4 - 40 rpm) Ugo 
Basile 7650 rotarod as described previously (Robertson et al., 2004). Each mouse was 
tested three times with at least 30 min rest period between trials. The mean latency to 
fall for these three trials was included in the final statistics.  
 
2.3. Immunohistochemistry and neuronal cell counts 
Mouse brains were collected, fixed with Carnoy’s fixative, processed, embedded and 
cut using a HM 310 microtome (Microm International). 8-µm-thick sections were 
mounted onto poly-L-lysine coated slides followed by staining with antibodies against 
tyrosine hydroxylase (TH, mouse monoclonal antibody, clone TH-2, Sigma) diluted 
1:1000. For detection secondary biotinylated anti-mouse or anti-rabbit antibodies, 
Elite plus kits (Vector laboratories) and 3,3’-diaminobenzidine as chromogen for the 
peroxidase reaction were used. The borders of the substantia nigra and ventral 
tegmental area (VTA) on these sections were outlined using distribution atlas of TH-
positive cells (Hokfelt et al., 1984). The number of TH-positive neurons was assessed 
by stereological counting as described in our previous publications (Al-Wandi et al. 
2010; Robertson et al., 2004). Briefly, the first section for counting was randomly 
chosen from the first 10 sections that included SNpc/VTA region. Starting from this 
section, every TH-positive cell with a clearly seen nucleus was counted on the every 
fifth section through the whole region. The Axiovision imaging program (Carl Zeiss 
Vision) was employed to measure diameters of 30 nuclei of dopaminergic neurons in 
the SNpc of every mouse brain included in this study. The nuclei were chosen 
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randomly and the distance measured as the horizontal length as they appeared on 
screen. A mean was calculated for each animal and used for Abercrombie’s correction 
(Abercrombie, 1946) to obtain an actual number of TH positive cells in the structure. 
 
2.4. High-pressure liquid chromography (HPLC) analysis of striatal 
neurochemicals 
Mouse dorsal striata were dissected, immediately snap-frozen in liquid nitrogen and 
kept at -80oC. Following extraction with 0.06 M HClO4, concentrations of striatal 
dopamine, 3,4-dihydroxyphenylacetic acid (DOPAC) and homovanillic acid (HVA) 
were measured by HPLC with electrochemical detection using a 4.6 x 150 mm 
Microsorb C18 reverse-phase column (Varian) and Decade II ECD with a Glassy 
carbon working electrode (Antec Leyden) set at +0.7 V with respect to a Ag/AgCl 
reference electrode. For measuring dopamine and its metabolites the mobile phase 
consisted of 12% methanol (v/v), 0.1M monosodium phosphate, 2.4mM 1-octane 
sulphonic acid (OSA), 0.68mM EDTA, pH 3.1. 
 
2.5. Statistical analysis 
All data are presented as means ± SEM. Non-parametric Kruskal-Wallis ANOVA 
with post hoc Whitney-Mann U-test were used for assessing statistical significance of 
the difference between groups. Chi-square test was used for dichotomous variables 
(completed or failed the inverted grid test) and Spearman's rank test  - to reveal 
correlation between various parameters within groups. Statistical analysis was 
performed using SPSS/PASW Statistics versions 16.0 or 18.0 (SPSS, Chicago, IL, 
USA), GraphPad Prism 4.0 (GraphPad Software, San Diego, CA, USA) and GB-
StatTM PPC 6.5.4 (Dynamic Microsystems, Inc., Silver Spring, MD, USA).  
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3. Results 
3.1. Mouse welfare and survival rate are not affected by inactivation of synuclein 
genes in any possible combination 
Experimental cohorts of seven synuclein-deficient genotypes and control wild type 
male mice were produced on C57Bl6J background as described in section 2.1. The 
majority of animals in all groups survived up to the age of 2 years at which stage they 
were tested, humanely sacrificed, and tissues collected for histological and 
biochemical assessments. No signs of neurological or other specific health problems 
were observed in any of the studied cohorts and some early casualties were caused by 
random events and not correlated with animals’ genotypes. Statistical analysis of the 
animal lifespan censored at 2 years demonstrated no difference between groups (Fig. 
1).   
 
3.2. Compromised motor performance of aged mice lacking β-synuclein  
At the age of 2 years motor performance of synuclein null mutant and control mice 
was tested in two experimental paradigms. The inverted grid test was used to assess 
coordination and grip strength, with accelerated rotarod test used to evaluate 
sensorimotor function, coordination and endurance. Animals lacking β-synuclein, 
either singularly or in combination with any other member(s) of the family, on 
average stayed on the inverted grid for a significantly shorter time than wild type 
mice, while animals expressing β-synuclein were indistinguishable from wild type 
mice even when lacking any or all other synucleins (Fig. 2). Moreover, only in groups 
of mice homozygous for inactivated β-synuclein gene was the success rate at the 
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inverted grid test significantly decreased compared to the wild type group (Fig. 2, 
Chi-square P value <0.05). Consistently, mice lacking β-synuclein gene performed 
significantly worse than wild type mice in the accelerated rotarod test, whereas the 
results for mice with intact β-synuclein alleles were not significantly different from 
the results for wild type animals (Fig. 3). 
 
3.3. Reduced dopamine content in the dorsal striatum of aged mice lacking α-
synuclein  
To test if attenuated motor performance of aged synuclein-deficient mice correlates 
with changes in the nigrostriatal dopaminergic system, levels of dopamine and its 
major metabolites, DOPAC and HVA were measured in extracts of the dorsal 
striatum of 2-year old mice using HPLC with electrochemical detection. A 
statistically significant reduction in the striatal dopamine level compared to its level in 
the aged wild type animals was observed in all groups of aged mice lacking α-
synuclein, but this level was unaffected in aged animals lacking other members of the 
family as long as α-synuclein remained present (Fig. 4). Moreover, there was no 
statistically significant difference in the striatal dopamine levels between mice that 
lacked only α-synuclein and those additionally lacking either β- or γ-synuclein, 
however deletion of all three synucleins did lead to a further reduction (Fig. 4). No 
statistically significant difference in levels of DOPAC and HVA were found between 
the studied groups, but the ratios of metabolites to dopamine, which are indicators of 
dopamine turnover, were significantly increased in aged mice lacking all three 
synucleins. In contrast, DOPAC to dopamine ratio was decreased in the striatum of 
mice lacking α- and β-synuclein (Table 1). 
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3.4. No age-dependent loss of dopaminergic neurons in the substantia nigra pars 
compacta of synuclein-deficient mice 
The number of TH-positive neurons was stereologically counted in the substantia 
nigra pars compacta of aged synuclein-deficient mice. Consistent with previously 
reported data, small but significant reductions in number of these neurons were 
observed in single α-synuclein, single γ-synuclein and α-synuclein/γ-synuclein double 
null mutant mice when compared to 2-year old wild type mice (Fig. 5) but degrees of 
these reductions were not greater than that in young adult mice of the same genotypes, 
suggesting that there is no further loss of dopaminergic neurons in aging synuclein-
deficient mice. Similar decreased number of neurons was found in mice deficient for 
α- and β-synuclein but the number of TH-positive neurons in the substantia nigra of 
2-year old triple synuclein null mutant mice was the same as in age-matched wild 
type mice (Fig. 5). 
We did not reveal statistically significant correlation between the deficiency of SNpc 
dopaminergic neurons and the late-onset decrease of striatal dopamine content or 
animal performance in the accelerated rotarod test. The absolute value for Spearman's 
rank correlation coefficient (rho) was less than 0.5 for all groups with exception of the 
group of beta-synuclein KO animals, where the rho value was 0.6 for number of cells 
vs. dopamine content but this correlation was still not statistically significant 
(p>0.05). 
 
 
4. Discussion 
In the current study cohorts of aged wild type mice and null mutant mice bearing 
inactivating mutations of the synuclein genes, all sharing the same C57Bl6 genetic 
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background were produced within a single breeding programme, and several 
experimental paradigms were used to assess the role of synucleins in maintenance of 
the normal nigrostriatal system function in the aging brain.  This approach allowed 
minimizing possible effects of indeterminate genetic and environmental factors when 
mice expressing different combinations of endogenous synucleins were compared. 
Several conclusions could be drawn from the results of these experiments. 
 
First, we explicitly demonstrated that at least in the undemanding laboratory 
environment, mice do not require synucleins for executing major physiological 
processes even at an old age. Animals of all single and double synuclein null mutant 
genotypes were born at the expected Mendelian frequencies, were fertile, did not 
display any obvious morphological or behavioral abnormalities, and no link was 
found between the absence of synuclein(s) and the life span of animals. These 
observations are consistent with previous reports from several laboratories that 
studied single or double synuclein null mutant mice (Abeliovich et al., 2000; Anwar 
et al., 2011; Cabin et al., 2002; Chandra et al., 2004; Dauer et al., 2002; Ninkina et al., 
2003; Robertson et al., 2004; Schluter et al., 2003). Moreover, while triple synuclein 
null mutant mice maintained on a mixed genetic background developed clearly 
evident neurological phenotype (e.g. pronounced clasping reflex) at old age and had 
significantly reduced average life span (Burre et al., 2010), in our cohorts maintained 
on C57Bl6 background, triple synuclein null mutant mice had the same life span as 
wild type mice and displayed no readily recognizable signs of neurological problems 
even at the age of 2 years. This suggests that certain unidentified factors can 
cooperate with the synuclein deficiency in triggering pathological changes in the 
aging nervous system. Consequently, synucleins can be considered as factors 
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increasing the robustness of animals and in particular, their nervous systems, to 
various challenges they might face in old age. 
 
This notion is supported by subtle (subthreshold for causing changes in general 
animal physiology) but statistically significant changes of certain parameters revealed 
in our experiments focused on the nigrostriatal system in aging mice. The loss of 
dopaminergic neurons was observed in the SNpc of α-, γ-, α/γ- and α/β-synuclein null 
mutant mice, but it was not progressive because the reduction in number of these 
neurons found in aged animals was not greater than the reduction seen in young 
animals of the same genotype (Garcia-Reitboeck et al., 2013; Robertson et al., 2004), 
indicating its developmental origin. Interestingly, animals lacking all three synuclein 
retain full complement of dopaminergic neurons in their SNpc. To explain this 
phenomenon molecular mechanisms should be revealed that switch on during 
development of dopaminergic neurons only in response to complete absence of 
synucleins. It is feasible that activation of these mechanisms secures efficient survival 
of SNpc neurons during critical developmental periods. 
 
A significant, ~20-30%, dopamine loss was found in the striatum of 2-year old mutant 
mice lacking α-synuclein either singularly or in combination with other synucleins 
(i.e. in α-, α/γ-, α/β- and α/β/γ-synuclein null mutant mice), but not in mice expressing 
this protein, independently of the presence of other synucleins. Moreover, additional 
depletion of other members of the family, either β-, or γ-synuclein, did not have an 
additive effect on the loss of striatal dopamine seen in α-synuclein depleted brains, 
whereas depletion of all three family members produced such effect. These 
observations indicate that only α-synuclein is vital for maintaining normal dopamine 
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metabolism in the nigrostriatal system of aged mice, whereas other two synucleins are 
also involved in this process but their influence is marginal. Results obtained in 
previously published studies are consistent with these conclusions. No statistically 
significant loss of dopamine has been detected in the striatum of young adult (4-6 
month old) α-, γ- and α/γ-synuclein null mutant mice (Robertson et al., 2004). 
Therefore, striatal dopamine deficiency in α- and α/γ-synuclein null mutant mice 
observed in the present study is an age-related phenotype. However, in the striatum of 
young adult α/β- and α/β/γ-synuclein null mutant mice dopamine loss comparable to 
that observed in aged mice has been reported (Anwar et al., 2011; Chandra et al., 
2004). Because even aged β/γ-synuclein null mutant mice do not display decreased 
striatal dopamine content, it is feasible to suggest that α-synuclein is the most efficient 
of three family members in maintaining normal level of this neurotransmitter, β-
synuclein is less efficient as it is able to compensate for α-synuclein loss in young but 
not in aged animals, and γ-synuclein does not play significant role in maintaining 
striatal dopamine level.  
 
An incomplete overlap between synuclein null mutations causing the loss of 
dopaminergic neurons and causing striatal dopamine depletion as well as the absence 
of statistically significant correlation between these two parameters suggest an 
independent nature of these events in the brain of synuclein-deficient mice.  
 
The increased metabolites to dopamine ratios (DOPAC:DA and HVA:DA) detected 
only in triple synuclein null mutant mice might imply that certain mechanisms 
compensating for reduced striatal dopamine levels by increasing turnover of this 
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neurotransmitter become activated only when the interfamily functional redundancy 
cannot be employed.   
 
The observed degree of striatal dopamine depletion was too small to cause a motor 
phenotype, which is commonly associated with the drop of dopamine content below 
30% of the level in the striatum of healthy animals. However, we found that balance 
and coordination was compromised in several lines of aged synuclein null mutant 
mice, although this set of genotypes did not fully overlap with either a set displaying 
deficiency in the number of SNpc dopamine neurons, or a set with depleted striatal 
dopamine content. A substantial decline of both inverted grid and rotarod 
performance was observed for all groups of animals lacking β-synuclein, i.e. β-, β/γ-, 
α/β- and α/β/γ-synuclein null mutant mice and once again, depletion of other 
synucleins had no additive effect. This suggests that the effect of β-synuclein 
deficiency on the motor performance of aged animals cannot be compensated by other 
members of the family. Since β-synuclein is highly expressed in many populations of 
brain neurons it cannot be ruled out that compromised balance and coordination of 
animals lacking this protein is due to an improper function of not only their 
nigrostriatal system but also other neuronal systems involved in regulation of motor 
functions.  
 
A functional redundancy within the synuclein family has been suggested based on a 
high degree of similarity between the family members. However, results of our 
studies suggest that each synuclein has a distinct set of functions, these three sets do 
not completely overlap and therefore, the loss of only some functions can be 
compensated by other family members, while the loss of other function can be 
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aggravated by the absence of other family members. Still sufficient in a fully adept 
nervous system, this incomplete compensation can cause functional deficiencies in 
combination with certain other events that on their own have no or only subtle 
detrimental effect on the nervous system function. As a gradual accumulation of such 
subtle functional defects is a common trait in the aging nervous system, an impact of 
the loss of a synuclein function becomes particularly detrimental for aged animals. 
This might be relevant to certain neurodegenerative conditions characterized by the 
depletion of a functional pool of particular synuclein due to its intensive aggregation 
and trapping in pathological inclusions.  
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8. Figure legends 
Fig. 1. Normal lifespan of synuclein null mutant mice. Kaplan-Meier survival plot 
demonstrates survival rate up to the age of 2 years in cohorts of wild type mice and 
mice carrying homozygous synuclein null alleles in any of seven possible 
combinations. Log rank and generalized Wilcoxon tests for equality of survival did 
not reveal significant difference between any of studied animal groups (P>0.05). The 
number of animals in groups: 35 (α+β+γ+), 23 (α-β+γ+), 21 (α+β-γ+), 33 (α+β+γ-), 29 (α-
β+γ-), 39 (α+β-γ-), 34 (α-β-γ+), 28 (α-β-γ-). 
 
Fig. 2. Animal performance on the inverted grid test. Animals were tested as 
described in section 2.2.1. The bar chart shows means±SEM of latency to fall for 
groups of 2-year old wild type and various synuclein knockout mice. Asterisks denote 
statistically significant difference between knockout and wild type groups (*p<0.05, 
Kruskal-Wallis ANOVA with post hoc Mann-Whitney test). For each group the 
number of animals tested and, in parentheses, stayed on the grid for the whole 60-
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second test in at least one of three trials is shown at the bottom of the corresponding 
bar.  
 
Fig. 3. Animal performance on the accelerating rotarod test. Animals were tested 
as described in section 2.2.2. The bar chart shows means±SEM of latency to fall for 
groups of 2-year old wild type and various synuclein knockout mice. Asterisks denote 
statistically significant difference between knockout and wild type groups (*p<0.05, 
**p<0.01, Kruskal-Wallis ANOVA with post hoc Mann-Whitney test). The number 
of animals tested for each group is shown at the bottom of the corresponding bar. 
 
Fig. 4. Dopamine levels in the dorsal striatum of 2-year old synuclein knockout 
mice. Dopamine concentrations (in nanograms per milligram of protein) were 
normalized to the mean value for wild type animals (100%). The bar chart shows 
means±SEM data obtained from the number of samples shown at the bottom of the 
corresponding bar. A statistically significant difference between knockout and wild 
type groups is denote by asterisks (*p<0.05, **p<0.01, Kruskal-Wallis ANOVA with 
post hoc Mann-Whitney test) and between α-synuclein and α/β/γ-synuclein knockout 
groups – by hash (#p<0.05). 
 
Fig. 5. The number of dopaminergic neurons in the substantia nigra pars 
compacta of 2-year old wild type and various synuclein knockout mice. (A) The 
bar chart shows means±SEM of stereologically counted TH-positive neurons per 
hemisphere.  Asterisks denote statistically significant difference between knockout 
and wild type groups (*p<0.05, **p<0.01, Kruskal-Wallis ANOVA with post hoc 
Mann-Whitney test). The number of samples processed for each group is shown at the 
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bottom of the corresponding bar. (B) Representative images of anti-TH 
immunostained sections through the midbrain of the wild type and synuclein deficient 
mice at the level between Bregma -3.0 to -3.2, where the border between SNpc and 
VTA is well defined. Insets show SNpc dopaminergic neurons at higher 
magnification. 
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Table 1. Ratios of metabolites to dopamine contents in the striatum of synuclein null mutant mice 
 
 
DOPAC:DA α+/β+/γ+ α-/β+/γ+ α+/β-/γ+ α+/β+/γ- α-/β+/γ- α+/β-/γ- α-/β-/γ+ α-/β-/γ- 
Average 0.1019 0.1044 0.0940 0.0981 0.1150 0.0893 0.0807* 0.1608** 
SEM 0.0062 0.0046 0.0047 0.0072 0.0043 0.0051 0.0053 0.0091 
 
 
        
HVA:DA α+/β+/γ+ α-/β+/γ+ α+/β-/γ+ α+/β+/γ- α-/β+/γ- α+/β-/γ- α-/β-/γ+ α-/β-/γ- 
Average 0.0827 0.0814 0.0908 0.0832 0.0969 0.0911 0.0980 0.1090* 
SEM 0.0136 0.0059 0.0033 0.0059 0.0058 0.0080 0.0060 0.0026 
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• Mice lacking synucleins in any combination are healthy and have normal 
lifespan  
• The lack of α-synuclein causes decrease of striatal dopamine level in aged 
mice  
• This effect of α-synuclein cannot be compensated by other family 
members 
• Aged mice lacking β-synuclein display compromised motor behaviour 
tests performance 
• This effect of β-synuclein cannot be compensated by other family 
members 
 
